Compare Sanmina Corp. with Similar Stocks
Dashboard
High Management Efficiency with a high ROE of 13.67%
Company has a low Debt to Equity ratio (avg) at times
Negative results in Dec 25
With ROE of 12.73%, it has a very attractive valuation with a 5.65 Price to Book Value
High Institutional Holdings at 100%
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
USD 14,792 Million (Small Cap)
44.00
NA
0.00%
0.31
12.64%
5.98
Total Returns (Price + Dividend) 
Sanmina Corp. for the last several years.
Risk Adjusted Returns v/s 
News

Sanmina Corp. Adjusts Evaluation Amid Mixed Technical Indicators and Strong Financial Performance
Sanmina Corp. has recently experienced a change in its evaluation, influenced by shifts in financial metrics and market dynamics. Key indicators show mixed signals, with some suggesting bullish trends. The company has demonstrated strong management efficiency and impressive operating cash flow, contributing to a stable financial outlook.
Read full news article Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 89 Schemes (59.04%)
Held by 140 Foreign Institutions (9.43%)
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 52.15% vs 2.68% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -0.38% vs -28.67% in Sep 2025
Annual Results Snapshot (Consolidated) - Sep'25
YoY Growth in year ended Sep 2025 is 7.40% vs -15.30% in Sep 2024
YoY Growth in year ended Sep 2025 is 11.98% vs -27.39% in Sep 2024






